Therapists take MDMA in training: will it boost Well-Being?

NCT ID NCT07102576

Recruiting now Knowledge-focused Sponsor: Rachel Yehuda Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study gives MDMA to 30 mental health providers who are learning to become MDMA-assisted therapists. The goal is to see how the drug affects their mental well-being, burnout, and self-confidence. Participants take MDMA in a therapeutic setting with a co-therapist pair, followed by a session the next day to integrate the experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MDMA hydrochloride (a psychoactive drug)
What this could lead to: If successful, this study could help understand how MDMA-assisted therapy affects therapists themselves, potentially improving training and reducing burnout.
What could go wrong: This is a very early, small, open-label study with no placebo group, so results may not be reliable or generalizable. MDMA can cause psychological distress, increased heart rate, and other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENTAL WELLBEING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MENTAL WELLBEING

Contacts and locations

Locations

The Parsons Research Center for Psychedelic Healing
RECRUITING

New York, New York, 10025, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.